Patents by Inventor Kelli RUNNING

Kelli RUNNING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-FOLR1 Immunoconjugate Dosing Regimens
    Publication number: 20220378694
    Abstract: Methods of administering immunoconjugates that bind to FOLR1 are provided. The methods comprise administering an anti-FOLR1 immunoconjugate to a person in need thereof, for example, a cancer patient, at a therapeutically effective dosing regimen that results in minimal adverse effects.
    Type: Application
    Filed: April 14, 2022
    Publication date: December 1, 2022
    Applicant: ImmunoGen, Inc.
    Inventors: Kelli Running, Robert A. Mastico, James J. O'Leary, Olga AB, Beni Wolf
  • Anti-FOLR1 Immunoconjugate Dosing Regimens
    Publication number: 20200046634
    Abstract: Methods of administering immunoconjugates that bind to FOLR1 are provided. The methods comprise administering an anti-FOLR1 immunoconjugate to a person in need thereof, for example, a cancer patient, at a therapeutically effective dosing regimen that results in minimal adverse effects.
    Type: Application
    Filed: April 19, 2019
    Publication date: February 13, 2020
    Applicant: ImmunoGen, Inc.
    Inventors: Kelli RUNNING, Robert A. MASTICO, James J. O'LEARY, Olga AB, Beni WOLF
  • ANTI-FOLR1 IMMUNOCONJUGATE DOSING REGIMENS
    Publication number: 20170239367
    Abstract: Methods of administering immunoconjugates that bind to FOLR1 are provided. The methods comprise administering an anti-FOLR1 immunoconjugate to a person in need thereof, for example, a cancer patient, at a therapeutically effective dosing regimen that results in minimal adverse effects.
    Type: Application
    Filed: December 22, 2016
    Publication date: August 24, 2017
    Inventors: Kelli RUNNING, Robert A. Mastico, James J. O'Leary, Olga Ab, Beni Wolf
  • Anti-FOLR1 Immunoconjugate Dosing Regimens
    Publication number: 20140363451
    Abstract: Methods of administering immunoconjugates that bind to FOLR1 are provided. The methods comprise administering an anti-FOLR1 immunoconjugate to a person in need thereof, for example, a cancer patient, at a therapeutically effective dosing regimen that results in minimal adverse effects.
    Type: Application
    Filed: May 13, 2014
    Publication date: December 11, 2014
    Applicant: ImmunoGen, Inc.
    Inventors: Kelli RUNNING, Robert A. Mastico, James J. O'Leary, Olga Ab, Beni Wolf